Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,775,503
New position
Shares Held
125,385
first reported quarter
Ownership
0.008%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#212
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Voleon Capital Management LP holds $188,095,544 across 10 Drug Manufacturers - General names. AZN ranks #4 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
53,311 | $63,942,818 | |
| 2 | ABBV |
AbbVie Inc.
|
172,753 | $43,471,564 | |
| 3 | MRK |
Merck & Co., Inc.
|
295,499 | $37,971,621 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
125,385 | $23,775,503 | |
| 5 | JNJ |
Johnson & Johnson
|
28,917 | $7,344,050 | |
| 6 | SNY |
Sanofi
|
89,489 | $3,817,600 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
64,106 | $3,693,787 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
23,049 | $2,912,010 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,775,503 | 125,385 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||